Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Dual serotonin and noradrenaline reuptake inhibitors: Focus on their differences.

International journal of psychiatry in clinical practice

Blier P.
PMID: 24921679
Int J Psychiatry Clin Pract. 2006;10:22-32. doi: 10.1080/13651500600645612.

There are three non-tricyclic dual serotonin (5-HT) and noradrenaline (NA) reuptake inhibitors (SNRIs) currently used in human therapeutics for psychiatric disorders. These medications differ in their in vitro potency to inhibit 5-HT and NA reuptake with differential ratios of...

Cite
Blier P. Dual serotonin and noradrenaline reuptake inhibitors: Focus on their differences. Int J Psychiatry Clin Pract. 2006;10:22-32doi: 10.1080/13651500600645612.
Blier, P. (2006). Dual serotonin and noradrenaline reuptake inhibitors: Focus on their differences. International journal of psychiatry in clinical practice, 1022-32. https://doi.org/10.1080/13651500600645612
Blier, Pierre. "Dual serotonin and noradrenaline reuptake inhibitors: Focus on their differences." International journal of psychiatry in clinical practice vol. 10 (2006): 22-32. doi: https://doi.org/10.1080/13651500600645612
Blier P. Dual serotonin and noradrenaline reuptake inhibitors: Focus on their differences. Int J Psychiatry Clin Pract. 2006;10:22-32. doi: 10.1080/13651500600645612. PMID: 24921679.
Copy Download .nbib Format: NLM
Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature.

Journal of clinical medicine

Ciobanu AM, Dionisie V, Neagu C, Bolog OM, Riga S, Popa-Velea O.
PMID: 34209089
J Clin Med. 2021 Jun 30;10(13). doi: 10.3390/jcm10132947.

Through the years, the available psychopharmacological treatments have expanded with numerous new drugs. Besides weight gain, gastro-intestinal problems or Parkinson-like symptoms, ocular adverse effects of psychiatric drugs have been reported. These adverse effects are not common, but can be...

Cite
Ciobanu AM, Dionisie V, Neagu C, et al. Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature. J Clin Med. 2021;10(13)doi: 10.3390/jcm10132947.
Ciobanu, A. M., Dionisie, V., Neagu, C., Bolog, O. M., Riga, S., & Popa-Velea, O. (2021). Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature. Journal of clinical medicine, 10(13), . https://doi.org/10.3390/jcm10132947
Ciobanu, Adela Magdalena, et al. "Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature." Journal of clinical medicine vol. 10,13 (2021). doi: https://doi.org/10.3390/jcm10132947
Ciobanu AM, Dionisie V, Neagu C, Bolog OM, Riga S, Popa-Velea O. Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature. J Clin Med. 2021 Jun 30;10(13). doi: 10.3390/jcm10132947. PMID: 34209089; PMCID: PMC8269427.
Copy Download .nbib Format: NLM
Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain.

International journal of psychiatry in clinical practice

Delgado PL.
PMID: 24921678
Int J Psychiatry Clin Pract. 2006;10:16-21. doi: 10.1080/13651500600637098.

Depression and painful symptoms occur frequently together. Over 75% of depressed patients report painful symptoms such as headache, stomach pain, neck and back pain as well as non-specific generalized pain. In addition, World Health Organization data have shown that...

Cite
Delgado PL. Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain. Int J Psychiatry Clin Pract. 2006;10:16-21doi: 10.1080/13651500600637098.
Delgado, P. L. (2006). Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain. International journal of psychiatry in clinical practice, 1016-21. https://doi.org/10.1080/13651500600637098
Delgado, Pedro L. "Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain." International journal of psychiatry in clinical practice vol. 10 (2006): 16-21. doi: https://doi.org/10.1080/13651500600637098
Delgado PL. Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain. Int J Psychiatry Clin Pract. 2006;10:16-21. doi: 10.1080/13651500600637098. PMID: 24921678.
Copy Download .nbib Format: NLM
Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study.

Journal of periodontal research

Hakam AE, Duarte PM, Mbadu MP, Aukhil I, da Silva HDP, Chang J.
PMID: 34622954
J Periodontal Res. 2022 Jan;57(1):75-84. doi: 10.1111/jre.12939. Epub 2021 Oct 08.

OBJECTIVE: Our study aimed to determine the relationship of antidepressant medicine use with periodontal diseases, exploring the association of different pharmacological classes of antidepressant with observations of clinical attachment loss (CAL) and alveolar bone level (BL) in patients with...

Cite
Hakam AE, Duarte PM, Mbadu MP, et al. Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study. J Periodontal Res. 2021;57(1):75-84doi: 10.1111/jre.12939.
Hakam, A. E., Duarte, P. M., Mbadu, M. P., Aukhil, I., da Silva, H. D. P., & Chang, J. (2022). Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study. Journal of periodontal research, 57(1), 75-84. https://doi.org/10.1111/jre.12939
Hakam, Abeer Essam, et al. "Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study." Journal of periodontal research vol. 57,1 (2022): 75-84. doi: https://doi.org/10.1111/jre.12939
Hakam AE, Duarte PM, Mbadu MP, Aukhil I, da Silva HDP, Chang J. Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study. J Periodontal Res. 2022 Jan;57(1):75-84. doi: 10.1111/jre.12939. Epub 2021 Oct 08. PMID: 34622954.
Copy Download .nbib Format: NLM
Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study.

Journal of periodontal research

Hakam AE, Duarte PM, Mbadu MP, Aukhil I, da Silva HDP, Chang J.
PMID: 34622954
J Periodontal Res. 2021 Oct 08; doi: 10.1111/jre.12939. Epub 2021 Oct 08.

OBJECTIVE: Our study aimed to determine the relationship of antidepressant medicine use with periodontal diseases, exploring the association of different pharmacological classes of antidepressant with observations of clinical attachment loss (CAL) and alveolar bone level (BL) in patients with...

Cite
Hakam AE, Duarte PM, Mbadu MP, et al. Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study. J Periodontal Res. 2021;doi: 10.1111/jre.12939.
Hakam, A. E., Duarte, P. M., Mbadu, M. P., Aukhil, I., da Silva, H. D. P., & Chang, J. (2021). Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study. Journal of periodontal research, . https://doi.org/10.1111/jre.12939
Hakam, Abeer Essam, et al. "Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study." Journal of periodontal research vol. (2021). doi: https://doi.org/10.1111/jre.12939
Hakam AE, Duarte PM, Mbadu MP, Aukhil I, da Silva HDP, Chang J. Association of different antidepressant classes with clinical attachment level and alveolar bone loss in patients with periodontitis: A retrospective study. J Periodontal Res. 2021 Oct 08; doi: 10.1111/jre.12939. Epub 2021 Oct 08. PMID: 34622954.
Copy Download .nbib Format: NLM
Selective Serotonin Re-Uptake Inhibitors for Premature Ejaculation in Adult Men: A Cochrane Systematic Review.

The world journal of men's health

Sathianathen NJ, Hwang EC, Mian R, Bodie JA, Soubra A, Lyon JA, Sultan S, Dahm P.
PMID: 35021307
World J Mens Health. 2022 Jan 02; doi: 10.5534/wjmh.210155. Epub 2022 Jan 02.

PURPOSE: Selective serotonin re-uptake inhibitors (SSRIs) are frequently used to treat premature ejaculation (PE) in men. We performed a Cochrane review to assess the efficacy of SSRI treatment for PE.MATERIALS AND METHODS: We extensively searched a range of databases...

Cite
Sathianathen NJ, Hwang EC, Mian R, et al. Selective Serotonin Re-Uptake Inhibitors for Premature Ejaculation in Adult Men: A Cochrane Systematic Review. World J Mens Health. 2022;doi: 10.5534/wjmh.210155.
Sathianathen, N. J., Hwang, E. C., Mian, R., Bodie, J. A., Soubra, A., Lyon, J. A., Sultan, S., & Dahm, P. (2022). Selective Serotonin Re-Uptake Inhibitors for Premature Ejaculation in Adult Men: A Cochrane Systematic Review. The world journal of men's health, . https://doi.org/10.5534/wjmh.210155
Sathianathen, Niranjan J, et al. "Selective Serotonin Re-Uptake Inhibitors for Premature Ejaculation in Adult Men: A Cochrane Systematic Review." The world journal of men's health vol. (2022). doi: https://doi.org/10.5534/wjmh.210155
Sathianathen NJ, Hwang EC, Mian R, Bodie JA, Soubra A, Lyon JA, Sultan S, Dahm P. Selective Serotonin Re-Uptake Inhibitors for Premature Ejaculation in Adult Men: A Cochrane Systematic Review. World J Mens Health. 2022 Jan 02; doi: 10.5534/wjmh.210155. Epub 2022 Jan 02. PMID: 35021307.
Copy Download .nbib Format: NLM
Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm.

Critical care medicine

Kelly JM, Rubenfeld GD, Masson N, Min A, Adhikari NKJ.
PMID: 28338497
Crit Care Med. 2017 Jun;45(6):e607-e616. doi: 10.1097/CCM.0000000000002308.

OBJECTIVE: Selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitors are among the most commonly prescribed drugs in patients admitted to the ICU. Our objective was to systematically review available literature for evidence of benefit or harm in ICU patients resulting from...

Cite
Kelly JM, Rubenfeld GD, Masson N, et al. Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm. Crit Care Med. 2017;45(6):e607-e616doi: 10.1097/CCM.0000000000002308.
Kelly, J. M., Rubenfeld, G. D., Masson, N., Min, A., & Adhikari, N. K. J. (2017). Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm. Critical care medicine, 45(6), e607-e616. https://doi.org/10.1097/CCM.0000000000002308
Kelly, John M, et al. "Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm." Critical care medicine vol. 45,6 (2017): e607-e616. doi: https://doi.org/10.1097/CCM.0000000000002308
Kelly JM, Rubenfeld GD, Masson N, Min A, Adhikari NKJ. Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or Harm. Crit Care Med. 2017 Jun;45(6):e607-e616. doi: 10.1097/CCM.0000000000002308. PMID: 28338497.
Copy Download .nbib Format: NLM
Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affective disorders.

Human psychopharmacology

Colombo A, Giordano F, Giorgetti F, Di Bernardo I, Bosi MF, Varinelli A, Cafaro R, Pileri P, Cetin I, Clementi E, Viganò CA, Dell'Osso B.
PMID: 33253437
Hum Psychopharmacol. 2021 May;36(3):e2772. doi: 10.1002/hup.2772. Epub 2020 Nov 30.

OBJECTIVE: Some studies have linked the use of selective serotonin reuptake inhibitors and selective serotonin and noradrenaline reuptake inhibitors (SSRIs/SNRIs) to the risk of perinatal complications. This study explored the relationship between pharmacokinetics and pharmacogenetics, SSRIs/SNRIs tolerability and effectiveness...

Cite
Colombo A, Giordano F, Giorgetti F, et al. Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affective disorders. Hum Psychopharmacol. 2020;36(3):e2772doi: 10.1002/hup.2772.
Colombo, A., Giordano, F., Giorgetti, F., Di Bernardo, I., Bosi, M. F., Varinelli, A., Cafaro, R., Pileri, P., Cetin, I., Clementi, E., Viganò, C. A., & Dell'Osso, B. (2021). Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affective disorders. Human psychopharmacology, 36(3), e2772. https://doi.org/10.1002/hup.2772
Colombo, Anna, et al. "Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affective disorders." Human psychopharmacology vol. 36,3 (2021): e2772. doi: https://doi.org/10.1002/hup.2772
Colombo A, Giordano F, Giorgetti F, Di Bernardo I, Bosi MF, Varinelli A, Cafaro R, Pileri P, Cetin I, Clementi E, Viganò CA, Dell'Osso B. Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affective disorders. Hum Psychopharmacol. 2021 May;36(3):e2772. doi: 10.1002/hup.2772. Epub 2020 Nov 30. PMID: 33253437.
Copy Download .nbib Format: NLM
Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development.

International journal of psychiatry in clinical practice

Montgomery S.
PMID: 24921676
Int J Psychiatry Clin Pract. 2006;10:5-11. doi: 10.1080/13651500600637049.

Although considerable progress has been made in improving the tolerability of antidepressant drugs, the classical tricyclic antidepressants (TCA) are still a standard for efficacy. The selective serotonin reuptake inhibitors (SSRI) are much better tolerated than the TCAs, but their...

Cite
Montgomery S. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development. Int J Psychiatry Clin Pract. 2006;10:5-11doi: 10.1080/13651500600637049.
Montgomery, S. (2006). Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development. International journal of psychiatry in clinical practice, 105-11. https://doi.org/10.1080/13651500600637049
Montgomery, Stuart. "Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development." International journal of psychiatry in clinical practice vol. 10 (2006): 5-11. doi: https://doi.org/10.1080/13651500600637049
Montgomery S. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development. Int J Psychiatry Clin Pract. 2006;10:5-11. doi: 10.1080/13651500600637049. PMID: 24921676.
Copy Download .nbib Format: NLM
Effect of Selected Antidepressants on Placental Homeostasis of Serotonin: Maternal and Fetal Perspectives.

Pharmaceutics

Horackova H, Karahoda R, Cerveny L, Vachalova V, Ebner R, Abad C, Staud F.
PMID: 34452265
Pharmaceutics. 2021 Aug 20;13(8). doi: 10.3390/pharmaceutics13081306.

Depression is a prevalent condition affecting up to 20% of pregnant women. Hence, more than 10% are prescribed antidepressant drugs, mainly serotonin reuptake inhibitors (SSRIs) and selective serotonin and noradrenaline reuptake inhibitors (SNRIs). We hypothesize that antidepressants disturb serotonin...

Cite
Horackova H, Karahoda R, Cerveny L, et al. Effect of Selected Antidepressants on Placental Homeostasis of Serotonin: Maternal and Fetal Perspectives. Pharmaceutics. 2021;13(8)doi: 10.3390/pharmaceutics13081306.
Horackova, H., Karahoda, R., Cerveny, L., Vachalova, V., Ebner, R., Abad, C., & Staud, F. (2021). Effect of Selected Antidepressants on Placental Homeostasis of Serotonin: Maternal and Fetal Perspectives. Pharmaceutics, 13(8), . https://doi.org/10.3390/pharmaceutics13081306
Horackova, Hana, et al. "Effect of Selected Antidepressants on Placental Homeostasis of Serotonin: Maternal and Fetal Perspectives." Pharmaceutics vol. 13,8 (2021). doi: https://doi.org/10.3390/pharmaceutics13081306
Horackova H, Karahoda R, Cerveny L, Vachalova V, Ebner R, Abad C, Staud F. Effect of Selected Antidepressants on Placental Homeostasis of Serotonin: Maternal and Fetal Perspectives. Pharmaceutics. 2021 Aug 20;13(8). doi: 10.3390/pharmaceutics13081306. PMID: 34452265; PMCID: PMC8397948.
Copy Download .nbib Format: NLM
Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice.

ISRN Pain

Katsuyama S, Aso H, Otowa A, Yagi T, Kishikawa Y, Komatsu T, Sakurada T, Nakamura H.
PMID: 27335884
ISRN Pain. 2014 Feb 23;2014:915464. doi: 10.1155/2014/915464. eCollection 2014.

Vincristine is an anticancer drug used to treat a variety of cancer types, but it frequently causes peripheral neuropathy. Neuropathic pain is often associated with the appearance of abnormal sensory signs, such as allodynia. Milnacipran and duloxetine, serotonin/noradrenaline reuptake...

Cite
Katsuyama S, Aso H, Otowa A, et al. Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice. ISRN Pain. 2014;2014:915464doi: 10.1155/2014/915464.
Katsuyama, S., Aso, H., Otowa, A., Yagi, T., Kishikawa, Y., Komatsu, T., Sakurada, T., & Nakamura, H. (2014). Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice. ISRN Pain, 2014915464. https://doi.org/10.1155/2014/915464
Katsuyama, Soh, et al. "Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice." ISRN Pain vol. 2014 (2014): 915464. doi: https://doi.org/10.1155/2014/915464
Katsuyama S, Aso H, Otowa A, Yagi T, Kishikawa Y, Komatsu T, Sakurada T, Nakamura H. Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice. ISRN Pain. 2014 Feb 23;2014:915464. doi: 10.1155/2014/915464. eCollection 2014. PMID: 27335884; PMCID: PMC4893398.
Copy Download .nbib Format: NLM
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials.

Neuropsychiatric disease and treatment

Zhong Z, Wang L, Wen X, Liu Y, Fan Y, Liu Z.
PMID: 29158677
Neuropsychiatr Dis Treat. 2017 Nov 07;13:2781-2796. doi: 10.2147/NDT.S141832. eCollection 2017.

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs) have been commonly prescribed for depression treatment. However, their effects on blood pressure are unclear.MATERIALS AND METHODS: Effects on blood pressure of depressive patients in two...

Cite
Zhong Z, Wang L, Wen X, et al. A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatr Dis Treat. 2017;13:2781-2796doi: 10.2147/NDT.S141832.
Zhong, Z., Wang, L., Wen, X., Liu, Y., Fan, Y., & Liu, Z. (2017). A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatric disease and treatment, 132781-2796. https://doi.org/10.2147/NDT.S141832
Zhong, Zhuoyuan, et al. "A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials." Neuropsychiatric disease and treatment vol. 13 (2017): 2781-2796. doi: https://doi.org/10.2147/NDT.S141832
Zhong Z, Wang L, Wen X, Liu Y, Fan Y, Liu Z. A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatr Dis Treat. 2017 Nov 07;13:2781-2796. doi: 10.2147/NDT.S141832. eCollection 2017. PMID: 29158677; PMCID: PMC5683798.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries